Identification of Biomarkers in Subjects With Coronary Syndrome (PLAQUE Study)
NCT06103357 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2024-03-05
Summary
The study will to test the levels of innovative biomarkers, such as miRNAs, in the blood of subjects underwent to angioplasty procedure according to standard clinical practice.
Conditions
- Coronary Syndrome
Interventions
- OTHER
-
blood sample collection
Before and after angioplasty, blood samples upstream and downstream of the coronary lesion will be taken, arterial sampling at the aortic root level will be performed, and peripheral venous blood will be collected.
Sponsors & Collaborators
-
Ministry of Health, Italy
collaborator OTHER_GOV -
Istituto Nazionale di Ricovero e Cura per Anziani
lead OTHER
Principal Investigators
-
Roberto Antonicelli, MD · IRCCS INRCA
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-06
- Primary Completion
- 2024-04-30
- Completion
- 2024-04-30
Countries
- Italy
Study Locations
More Related Trials
-
Correlation of Artherosclerotic Plaque Volume and Intima Media Thickness With Soluble P-selectin
NCT01895725 ·Status: ACTIVE_NOT_RECRUITING
-
A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.
NCT05984537 ·Status: RECRUITING ·Phase: PHASE4
-
Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)
NCT01718288 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiovascular Inflammation Reduction Trial
NCT01594333 ·Status: COMPLETED ·Phase: PHASE3
-
Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans
NCT01067339 ·Status: COMPLETED ·Phase: PHASE3
-
PIPAF Platelets in the Pathogenesis of Ageing Associated Frailty
NCT05798637 ·Status: UNKNOWN
-
Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II
NCT05764356 ·Status: NOT_YET_RECRUITING
-
Single-center, Prospective Cohort Study of PD-1 Inhibitors on Clinical Outcomes of Carotid Plaques in Tumor Patients
NCT05549336 ·Status: UNKNOWN
-
Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease
NCT06572267 ·Status: RECRUITING ·Phase: PHASE2
-
Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque
NCT00636766 ·Status: COMPLETED ·Phase: NA
-
Molecular Mechanisms and Carotid Atherosclerosis
NCT03962686 ·Status: COMPLETED
-
A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
NCT05563246 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events
NCT05537571 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack
NCT07301034 ·Status: RECRUITING ·Phase: PHASE3
-
Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD
NCT04027712 ·Status: UNKNOWN
-
Study of ONO-1101 in Patients Scheduled for Coronary Angiography
NCT00560209 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)
NCT06204237 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Carotid Plaque Screening Trial in Smokers
NCT00548665 ·Status: COMPLETED ·Phase: PHASE4
-
Peripheral Artery Disease in Patients With Stable Coronary Artery Disease in General Practice: Prevalence, Management and Clinical Outcomes.
NCT03921905 ·Status: COMPLETED
-
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine
NCT06215989 ·Status: RECRUITING ·Phase: NA
-
Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients
NCT03506633 ·Status: COMPLETED ·Phase: NA
-
L-Arginine in the Treatment of Peripheral Arterial Disease
NCT00284076 ·Status: COMPLETED ·Phase: NA
-
Effect of Evolocumab on Coronary Plaque Characteristics
NCT04710368 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of the Antidiabetic Drug Dapagliflozin on the Coronary Macrovascular and Microvascular Function in Type 2 Diabetic Patients
NCT05392959 ·Status: TERMINATED ·Phase: PHASE4
-
ESCALATion of Medical Therapy Following Multimodality Plaque Evaluation in High-risk Chronic Coronary Syndromes
NCT06469528 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3